[fd8900]: / processing / MACCROBAT / 28202869.ann

Download this file

413 lines (412 with data), 13.5 kB

T1	Age 2 13	34-year-old
T2	Personal_background 14 22	Japanese
T3	Sex 23 28	woman
T4	Disease_disorder 48 52	MCTD
E1	Disease_disorder:T4 
#1	AnnotatorNotes E1	mixed connective tissue disease
T5	Disease_disorder 74 94	Raynaud's phenomenon
E2	Disease_disorder:T5 
T6	Sign_symptom 96 108	pancytopenia
E3	Sign_symptom:T6 
T7	Diagnostic_procedure 126 143	creatinine kinase
E4	Diagnostic_procedure:T7 
T8	Detailed_description 119 125	plasma
R1	MODIFY Arg1:T8 Arg2:E4	
T10	Diagnostic_procedure 168 188	U1-ribonucleoprotein
E5	Diagnostic_procedure:T10 
T12	Date 192 196	2005
E6	Date:T12 
T13	Medication 219 231	prednisolone
E7	Medication:T13 
T14	Dosage 210 215	10 mg
T15	Dosage 232 237	daily
R4	MODIFY Arg1:T15 Arg2:E7	
R5	MODIFY Arg1:T14 Arg2:E7	
T9	Lab_value 110 118	elevated
E8	Lab_value:T9 
R2	MODIFY Arg1:E8 Arg2:E4	
T11	Lab_value 149 167	antibodies against
E9	Lab_value:T11 
R3	MODIFY Arg1:E9 Arg2:E5	
T16	Diagnostic_procedure 239 275	Pulmonary arterial systolic pressure
E10	Diagnostic_procedure:T16 
T18	Diagnostic_procedure 289 305	echocardiography
E11	Diagnostic_procedure:T18 
R7	SUB_PROCEDURE Arg1:E11 Arg2:E10	
T19	Lab_value 310 327	slightly elevated
E12	Lab_value:T19 
T20	Lab_value 329 336	48 mmHg
E13	Lab_value:T20 
R8	MODIFY Arg1:E12 Arg2:E10	
R9	MODIFY Arg1:E13 Arg2:E10	
T21	Date 341 345	2006
E14	Date:T21 
T22	Sign_symptom 368 387	shortness of breath
E15	Sign_symptom:T22 
T23	Activity 391 406	physical effort
E16	Activity:T23 
T24	Detailed_description 356 367	progressive
R10	MODIFY Arg1:T24 Arg2:E15	
T25	Date 410 414	2011
E17	Date:T25 
T28	Diagnostic_procedure 478 510	mean pulmonary arterial pressure
E19	Diagnostic_procedure:T28 
T26	Disease_disorder 416 447	Pulmonary arterial hypertension
E18	Disease_disorder:T26 
T27	Lab_value 467 474	74 mmHg
E20	Lab_value:T27 
T30	Diagnostic_procedure 512 516	mPAP
E21	Diagnostic_procedure:T30 
R12	IDENTICAL Arg1:E21 Arg2:E19	
R11	MODIFY Arg1:E20 Arg2:E19	
T29	Diagnostic_procedure 531 558	right heart catheterization
E22	Diagnostic_procedure:T29 
T31	Diagnostic_procedure 560 563	RHC
E23	Diagnostic_procedure:T31 
R14	IDENTICAL Arg1:E23 Arg2:E22	
T32	Date 568 572	2012
E24	Date:T32 
T33	Medication 597 622	immunosuppressive therapy
E25	Medication:T33 
T34	Medication 574 590	Cyclophosphamide
E26	Medication:T34 
R15	SUB_PROCEDURE Arg1:E26 Arg2:E25	
A1	POLARITY E25 NEG
T35	Sign_symptom 674 693	menopausal symptoms
E27	Sign_symptom:T35 
A2	POLARITY E27 UNCERTAIN
T36	Detailed_description 668 673	early
R16	MODIFY Arg1:T36 Arg2:E27	
T37	Dosage 710 720	250 mg/day
T38	Medication 724 732	bosentan
E28	Medication:T38 
T39	Dosage 737 747	120 μg/day
T40	Medication 751 760	beraprost
E29	Medication:T40 
R17	MODIFY Arg1:T39 Arg2:E29	
R18	MODIFY Arg1:T37 Arg2:E28	
T41	Date 788 800	January 2014
E30	Date:T41 
T42	Sign_symptom 806 813	dyspnea
E31	Sign_symptom:T42 
A3	TREND E31 INC
T43	Diagnostic_procedure 828 848	WHO functional class
E32	Diagnostic_procedure:T43 
T44	Lab_value 849 851	IV
E33	Lab_value:T44 
R19	MODIFY Arg1:E33 Arg2:E32	
T45	Clinical_event 866 874	admitted
E34	Clinical_event:T45 
T46	Nonbiological_location 882 890	hospital
R20	MODIFY Arg1:T46 Arg2:E34	
T47	Diagnostic_procedure 894 914	physical examination
E35	Diagnostic_procedure:T47 
T48	Diagnostic_procedure 926 949	systemic blood pressure
E36	Diagnostic_procedure:T48 
T49	Lab_value 922 925	low
E37	Lab_value:T49 
T50	Lab_value 951 961	89/61 mmHg
E38	Lab_value:T50 
R21	MODIFY Arg1:E38 Arg2:E36	
R22	MODIFY Arg1:E37 Arg2:E36	
T51	Sign_symptom 964 975	tachycardia
E39	Sign_symptom:T51 
T52	Lab_value 977 984	104/min
E40	Lab_value:T52 
R23	MODIFY Arg1:E40 Arg2:E39	
T53	Diagnostic_procedure 991 1009	blood oxygen level
E41	Diagnostic_procedure:T53 
T54	Lab_value 987 990	low
E42	Lab_value:T54 
R24	MODIFY Arg1:E42 Arg2:E41	
T55	Diagnostic_procedure 1011 1041	percutaneous oxygen saturation
E43	Diagnostic_procedure:T55 
R25	SUB_PROCEDURE Arg1:E43 Arg2:E41	
T56	Diagnostic_procedure 1043 1047	SpO2
E44	Diagnostic_procedure:T56 
R26	IDENTICAL Arg1:E44 Arg2:E43	
T57	Lab_value 1049 1052	95%
E45	Lab_value:T57 
R27	MODIFY Arg1:E45 Arg2:E43	
T58	Sign_symptom 1070 1080	distension
E46	Sign_symptom:T58 
T59	Biological_structure 1055 1069	jugular venous
R28	MODIFY Arg1:T59 Arg2:E46	
T60	Sign_symptom 1102 1107	edema
E47	Sign_symptom:T60 
T61	Detailed_description 1093 1101	systemic
T62	Severity 1086 1092	severe
R29	MODIFY Arg1:T62 Arg2:E47	
R30	MODIFY Arg1:T61 Arg2:E47	
T63	Sign_symptom 1116 1124	crackles
E48	Sign_symptom:T63 
T64	Detailed_description 1109 1115	Coarse
R31	MODIFY Arg1:T64 Arg2:E48	
T65	Detailed_description 1129 1133	loud
T66	Sign_symptom 1134 1163	pulmonic valve closure sounds
E49	Sign_symptom:T66 
R32	MODIFY Arg1:T65 Arg2:E49	
T67	Diagnostic_procedure 1209 1227	6-minute walk test
E50	Diagnostic_procedure:T67 
A4	POLARITY E50 NEG
T68	Sign_symptom 1242 1249	dyspnea
E51	Sign_symptom:T68 
T69	Severity 1235 1241	severe
R33	MODIFY Arg1:T69 Arg2:E51	
T70	Diagnostic_procedure 1251 1274	Laboratory examinations
E52	Diagnostic_procedure:T70 
T71	Diagnostic_procedure 1298 1323	brain natriuretic peptide
E53	Diagnostic_procedure:T71 
T72	Detailed_description 1291 1297	plasma
R34	MODIFY Arg1:T72 Arg2:E53	
T73	Lab_value 1282 1290	elevated
E54	Lab_value:T73 
T74	Diagnostic_procedure 1325 1328	BNP
E55	Diagnostic_procedure:T74 
R35	IDENTICAL Arg1:E55 Arg2:E53	
R36	MODIFY Arg1:E54 Arg2:E53	
T75	Lab_value 1337 1348	929.4 pg/mL
E56	Lab_value:T75 
R37	MODIFY Arg1:E56 Arg2:E53	
T76	Sign_symptom 1351 1360	hypoxemia
E57	Sign_symptom:T76 
T77	Diagnostic_procedure 1362 1366	PaO2
E58	Diagnostic_procedure:T77 
T78	Lab_value 1367 1376	62.5 mmHg
E59	Lab_value:T78 
R38	MODIFY Arg1:E59 Arg2:E58	
T79	Diagnostic_procedure 1378 1383	PaCO2
E60	Diagnostic_procedure:T79 
T80	Lab_value 1384 1393	27.1 mmHg
E61	Lab_value:T80 
R39	SUB_PROCEDURE Arg1:E53 Arg2:E52	
R40	SUB_PROCEDURE Arg1:E58 Arg2:E52	
R41	SUB_PROCEDURE Arg1:E60 Arg2:E52	
R42	MODIFY Arg1:E61 Arg2:E60	
T81	Lab_value 1404 1434	presence of antibodies against
E62	Lab_value:T81 
T82	Diagnostic_procedure 1435 1455	U1-ribonucleoprotein
E63	Diagnostic_procedure:T82 
R43	MODIFY Arg1:E62 Arg2:E63	
T83	Lab_value 1457 1466	97.9 U/mL
E64	Lab_value:T83 
R44	MODIFY Arg1:E64 Arg2:E63	
R45	SUB_PROCEDURE Arg1:E63 Arg2:E52	
T84	Diagnostic_procedure 1479 1501	antinuclear antibodies
E65	Diagnostic_procedure:T84 
T85	Lab_value 1503 1508	1:640
E66	Lab_value:T85 
T86	Lab_value 1510 1526	speckled pattern
E67	Lab_value:T86 
R46	MODIFY Arg1:E66 Arg2:E65	
R47	MODIFY Arg1:E67 Arg2:E65	
R48	SUB_PROCEDURE Arg1:E65 Arg2:E52	
T87	Diagnostic_procedure 1537 1542	X-ray
E68	Diagnostic_procedure:T87 
T88	Biological_structure 1531 1536	chest
R49	MODIFY Arg1:T88 Arg2:E68	
T89	Sign_symptom 1550 1558	enlarged
E69	Sign_symptom:T89 
T90	Biological_structure 1559 1577	pulmonary arteries
R50	MODIFY Arg1:T90 Arg2:E69	
T91	Sign_symptom 1582 1594	cardiomegaly
E70	Sign_symptom:T91 
T92	Diagnostic_procedure 1605 1622	Electrocardiogram
E71	Diagnostic_procedure:T92 
T93	Sign_symptom 1630 1646	P wave elevation
E72	Sign_symptom:T93 
T94	Detailed_description 1654 1665	V1-V2 leads
R51	MODIFY Arg1:T94 Arg2:E72	
T95	Diagnostic_procedure 1667 1670	RHC
E73	Diagnostic_procedure:T95 
T96	Diagnostic_procedure 1693 1697	mPAP
E74	Diagnostic_procedure:T96 
T97	Lab_value 1684 1692	elevated
E75	Lab_value:T97 
T98	Lab_value 1699 1706	65 mmHg
E76	Lab_value:T98 
R52	MODIFY Arg1:E75 Arg2:E74	
R53	MODIFY Arg1:E76 Arg2:E74	
T99	Diagnostic_procedure 1720 1753	pulmonary arterial wedge pressure
E77	Diagnostic_procedure:T99 
T17	Lab_value 1755 1762	12 mmHg
E78	Lab_value:T17 
T100	Lab_value 1713 1719	normal
E79	Lab_value:T100 
R6	MODIFY Arg1:E79 Arg2:E77	
R54	MODIFY Arg1:E78 Arg2:E77	
T101	Lab_value 1765 1769	high
E80	Lab_value:T101 
T102	Diagnostic_procedure 1770 1799	pulmonary vascular resistance
E81	Diagnostic_procedure:T102 
T103	Lab_value 1801 1820	1,547 dyne・sec・cm-5
E82	Lab_value:T103 
R55	MODIFY Arg1:E82 Arg2:E81	
R56	MODIFY Arg1:E80 Arg2:E81	
T104	Lab_value 1827 1836	decreased
E83	Lab_value:T104 
T105	Diagnostic_procedure 1837 1851	cardiac output
E84	Diagnostic_procedure:T105 
T106	Lab_value 1853 1880	cardiac index 1.69 L/min/m2
E85	Lab_value:T106 
R13	MODIFY Arg1:E85 Arg2:E84	
R57	MODIFY Arg1:E83 Arg2:E84	
T107	Diagnostic_procedure 1885 1911	ventilation/perfusion scan
E86	Diagnostic_procedure:T107 
T108	Disease_disorder 1931 1956	pulmonary thromboembolism
E87	Disease_disorder:T108 
A5	POLARITY E87 NEG
T109	Disease_disorder 1970 2007	chronic obstructive pulmonary disease
E88	Disease_disorder:T109 
A6	POLARITY E88 NEG
T110	Disease_disorder 2011 2037	interstitial lung diseases
E89	Disease_disorder:T110 
A7	POLARITY E89 NEG
T111	Diagnostic_procedure 2054 2073	computed tomography
E90	Diagnostic_procedure:T111 
T112	Sign_symptom 2079 2086	dyspnea
E91	Sign_symptom:T112 
T113	Disease_disorder 2141 2144	PAH
E92	Disease_disorder:T113 
#2	AnnotatorNotes E92	pulmonary arterial hypertension
T114	Disease_disorder 2125 2129	MCTD
E93	Disease_disorder:T114 
R58	CAUSE Arg1:E93 Arg2:E92	
R59	CAUSE Arg1:E92 Arg2:E91	
T115	Medication 2169 2177	bosentan
E94	Medication:T115 
T116	Medication 2182 2191	beraprost
E95	Medication:T116 
T117	Therapeutic_procedure 2216 2234	supportive therapy
E96	Therapeutic_procedure:T117 
T118	Therapeutic_procedure 2240 2262	oxygen supplementation
E97	Therapeutic_procedure:T118 
R60	SUB_PROCEDURE Arg1:E97 Arg2:E96	
T119	Medication 2267 2276	diuretics
E98	Medication:T119 
R61	SUB_PROCEDURE Arg1:E98 Arg2:E96	
T120	Dosage 2278 2287	40 mg/day
T121	Medication 2291 2301	furosemide
E99	Medication:T121 
R62	MODIFY Arg1:T120 Arg2:E99	
T122	Dosage 2318 2327	60 mg/day
T123	Medication 2331 2341	sildenafil
E100	Medication:T123 
R64	MODIFY Arg1:T122 Arg2:E100	
T124	Medication 2386 2395	beraprost
E101	Medication:T124 
T125	Dosage 2353 2382	gradual increment in the dose
R65	MODIFY Arg1:T125 Arg2:E101	
T126	Sign_symptom 2448 2455	dyspnea
E102	Sign_symptom:T126 
A8	TREND E102 STAY
T127	Diagnostic_procedure 2491 2494	BNP
E103	Diagnostic_procedure:T127 
T128	Detailed_description 2484 2490	plasma
R66	MODIFY Arg1:T128 Arg2:E103	
T129	Lab_value 2501 2510	increased
E104	Lab_value:T129 
R67	MODIFY Arg1:E104 Arg2:E103	
T130	Medication 2512 2516	IVCY
E105	Medication:T130 
#3	AnnotatorNotes E105	Intravenous cyclophosphamide
T131	Dosage 2518 2542	750 mg/m2, every 4 weeks
R68	MODIFY Arg1:T131 Arg2:E105	
T132	Medication 2575 2587	prednisolone
E106	Medication:T132 
T133	Dosage 2605 2616	60 mg daily
R69	MODIFY Arg1:T133 Arg2:E106	
T134	Sign_symptom 2622 2629	dyspnea
E107	Sign_symptom:T134 
A9	POLARITY E107 NEG
T135	Diagnostic_procedure 2683 2701	6-minute walk test
E108	Diagnostic_procedure:T135 
T136	Lab_value 2703 2708	260 m
E109	Lab_value:T136 
T137	Diagnostic_procedure 2710 2722	minimum SpO2
E110	Diagnostic_procedure:T137 
T138	Lab_value 2723 2727	95 %
E111	Lab_value:T138 
R70	MODIFY Arg1:E109 Arg2:E108	
R71	MODIFY Arg1:E111 Arg2:E110	
T139	Diagnostic_procedure 2741 2744	BNP
E112	Diagnostic_procedure:T139 
T140	Detailed_description 2734 2740	plasma
R72	MODIFY Arg1:T140 Arg2:E112	
T141	Lab_value 2756 2765	decreased
E113	Lab_value:T141 
R73	MODIFY Arg1:E113 Arg2:E112	
T142	Medication 2790 2794	IVCY
E114	Medication:T142 
T143	Date 2805 2821	Six months after
E115	Date:T143 
T144	Clinical_event 2826 2835	admission
E116	Clinical_event:T144 
T145	Diagnostic_procedure 2849 2852	RHC
E117	Diagnostic_procedure:T145 
T146	Diagnostic_procedure 2871 2875	mPAP
E118	Diagnostic_procedure:T146 
T147	Lab_value 2862 2870	improved
E119	Lab_value:T147 
T148	Lab_value 2883 2890	53 mmHg
E120	Lab_value:T148 
R74	MODIFY Arg1:E120 Arg2:E118	
R75	MODIFY Arg1:E119 Arg2:E118	
T149	Diagnostic_procedure 2893 2922	pulmonary vascular resistance
E121	Diagnostic_procedure:T149 
R76	MODIFY Arg1:E119 Arg2:E121	
T150	Lab_value 2933 2952	1,116 dyne・sec・cm-5
E122	Lab_value:T150 
R77	MODIFY Arg1:E122 Arg2:E121	
T151	Diagnostic_procedure 2959 2972	cardiac index
E123	Diagnostic_procedure:T151 
T152	Lab_value 2982 2995	1.83 L/min/m2
E124	Lab_value:T152 
R78	MODIFY Arg1:E124 Arg2:E123	
R79	MODIFY Arg1:E119 Arg2:E123	
T153	Sign_symptom 3025 3031	stable
E125	Sign_symptom:T153 
T154	Date 3072 3087	18 months after
E126	Date:T154 
T155	Clinical_event 3092 3101	admission
E127	Clinical_event:T155 
T156	Medication 3134 3145	prostanoids
E128	Medication:T156 
A10	POLARITY E128 UNCERTAIN
T157	Administration 3123 3133	parenteral
R80	MODIFY Arg1:T157 Arg2:E128	
T158	Therapeutic_procedure 3149 3169	lung transplantation
E129	Therapeutic_procedure:T158 
A11	POLARITY E129 UNCERTAIN
*	OVERLAP E1 E2 E3 E4 E5 E6
R81	BEFORE Arg1:E6 Arg2:E7	
R82	BEFORE Arg1:E7 Arg2:E10	
*	OVERLAP E10 E14
R83	BEFORE Arg1:E14 Arg2:E15	
R84	CAUSE Arg1:E16 Arg2:E15	
*	OVERLAP E15 E16 E17
R85	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E22 E24 E26 E27
R86	BEFORE Arg1:E27 Arg2:E28	
*	OVERLAP E28 E29
R87	BEFORE Arg1:E29 Arg2:E30	
*	OVERLAP E30 E31 E32 E34 E35 E36 E39 E41 E46 E47 E48 E49 E50 E51 E52 E57 E68 E69 E70 E71 E72 E73 E74 E77 E81 E84 E86 E87 E88 E89 E90 E91 E93 E92 E94 E95
R88	BEFORE Arg1:E95 Arg2:E96	
R63	SUB_PROCEDURE Arg1:E99 Arg2:E98	
*	OVERLAP E96 E100 E101
R89	BEFORE Arg1:E101 Arg2:E102	
*	OVERLAP E102 E103
R90	BEFORE Arg1:E103 Arg2:E105	
*	OVERLAP E105 E106
R91	BEFORE Arg1:E106 Arg2:E107	
*	OVERLAP E107 E108 E110 E112
R92	AFTER Arg1:E112 Arg2:E114	
R93	BEFORE Arg1:E114 Arg2:E115	
R94	AFTER Arg1:E115 Arg2:E116	
R95	BEFORE Arg1:E116 Arg2:E117	
*	OVERLAP E117 E118 E121 E123
R96	BEFORE Arg1:E123 Arg2:E125	
*	OVERLAP E125 E126
R97	AFTER Arg1:E126 Arg2:E127	
R98	BEFORE Arg1:E127 Arg2:E128	
*	OVERLAP E128 E129